hydroxychloroquine has been researched along with Granulomatous Mastitis in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Granulomatous Mastitis: A rare, benign, inflammatory breast disease occurring in premenopausal women shortly after a recent pregnancy. The origin is unknown but it is commonly mistaken for malignancy and sometimes associated with BREAST FEEDING and the use of ORAL CONTRACEPTIVES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Here we report a case of a 22-year-old systemic lupus erythematosus (SLE) patient with three years' disease duration, stable on prednisone and hydroxychloroquine, who was found to have prolactinoma and recurrent GM after she discontinued medication on her own accord." | 5.40 | An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine. ( Shi, TY; Yang, YJ; Zhang, FC; Zhang, LN, 2014) |
| "Here we report a case of a 22-year-old systemic lupus erythematosus (SLE) patient with three years' disease duration, stable on prednisone and hydroxychloroquine, who was found to have prolactinoma and recurrent GM after she discontinued medication on her own accord." | 1.40 | An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine. ( Shi, TY; Yang, YJ; Zhang, FC; Zhang, LN, 2014) |
| "Most patients had at least one recurrence (18/23, 78%)." | 1.39 | Long-term outcome in idiopathic granulomatous mastitis: a western multicentre study. ( Cabane, J; Chiche, L; Costedoat-Chalumeau, N; Cottereau, A; De Faucal, P; Graveleau, J; Hachulla, E; Hamidou, M; Hello, M; Lavigne, C; Néel, A; Rondeau-Lutz, M; Seiberras, S; Tournemaine, N, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Néel, A | 1 |
| Hello, M | 1 |
| Cottereau, A | 1 |
| Graveleau, J | 1 |
| De Faucal, P | 1 |
| Costedoat-Chalumeau, N | 1 |
| Rondeau-Lutz, M | 1 |
| Lavigne, C | 1 |
| Chiche, L | 1 |
| Hachulla, E | 1 |
| Seiberras, S | 1 |
| Cabane, J | 1 |
| Tournemaine, N | 1 |
| Hamidou, M | 1 |
| Zhang, LN | 1 |
| Shi, TY | 1 |
| Yang, YJ | 1 |
| Zhang, FC | 1 |
2 other studies available for hydroxychloroquine and Granulomatous Mastitis
| Article | Year |
|---|---|
Long-term outcome in idiopathic granulomatous mastitis: a western multicentre study.
Topics: Adult; Colchicine; Drug Utilization; Female; Glucocorticoids; Granulomatous Mastitis; Humans; Hydrox | 2013 |
An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine.
Topics: Bromocriptine; Female; Granulomatous Mastitis; Hormone Antagonists; Humans; Hydroxychloroquine; Lupu | 2014 |